rofecoxib has been researched along with Cardiac Remodeling, Ventricular in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The evidence is compelling for a role of inflammation in cardiovascular diseases; however, the chronic use of anti-inflammatory drugs for these indications has been disappointing." | 1.35 | Differential effects of p38 mitogen-activated protein kinase and cyclooxygenase 2 inhibitors in a model of cardiovascular disease. ( Aiyar, N; Behm, DJ; Bentley, RG; Coatney, RW; Doe, CP; Eybye, ME; Maniscalco, K; Olzinski, AR; Westfall, TD; Willette, RN; Zhao, S, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Willette, RN | 1 |
| Eybye, ME | 1 |
| Olzinski, AR | 1 |
| Behm, DJ | 1 |
| Aiyar, N | 1 |
| Maniscalco, K | 1 |
| Bentley, RG | 1 |
| Coatney, RW | 1 |
| Zhao, S | 1 |
| Westfall, TD | 1 |
| Doe, CP | 1 |
| Jugdutt, BI | 1 |
2 other studies available for rofecoxib and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Differential effects of p38 mitogen-activated protein kinase and cyclooxygenase 2 inhibitors in a model of cardiovascular disease.
Topics: Aldosterone; Animals; Blood Pressure; Cardiovascular Diseases; Cyclooxygenase 1; Cyclooxygenase 2; C | 2009 |
Cyclooxygenase inhibition and adverse remodeling during healing after myocardial infarction.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Cardiovascular Diseases; Celecoxib | 2007 |